Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota

Annals of the American Thoracic Society

Volumn 11, Issue 7, 2014, Pages 1049-1055

  Brown, Perry S ^a   Pope, Christopher E ^b   Marsh, Robyn L ^c   Qin, Xuan ^b   McNamara, Sharon ^b   Gibson, Ronald ^b   Burns, Jane L ^b   Deutsch, Gail ^d   Hoffman, Lucas R ^b,d  

^a St Luke's Boise Regional Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cystic fibrosis; Infection; Lobectomy; Microbiota

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE; RNA 16S; SULTAMICILLIN; BACTERIAL DNA;

ARTICLE; ATELECTASIS; BACTERIUM CULTURE; BREATHING EXERCISE; BRONCHIECTASIS; CASE REPORT; CHILD; CLAVISPORA LUSITANIAE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG DISEASE; LUNG LOBECTOMY; LUNG PARENCHYMA; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIAL DIVERSITY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOGENESIS; PHYLOGENY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROPIONIBACTERIUM; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; RALSTONIA PICKETTII; RNA GENE; SERRATIA MARCESCENS; SPECIES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; THORAX RADIOGRAPHY; BRONCHITIS; FOLLOW UP; LUNG; LUNG LAVAGE; LUNG RESECTION; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PROCEDURES; RADIOGRAPHY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE CULTURE TECHNIQUE; TREATMENT OUTCOME;

BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DNA, BACTERIAL; FOLLOW-UP STUDIES; HUMANS; LUNG; MICROBIOTA; PNEUMONECTOMY; RADIOGRAPHY, THORACIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE CULTURE TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84911888639     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201311-383OC     Document Type: Article

References (38)

1. Sibley CD, Surette MG. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can J Microbiol 2011; 57:69-77.
2. Döring G, Flume P, Heijerman H, Elborn JS; Consensus Study Group. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 2012;11:461-479.
3. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007;104:20529-20533.
4. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. The adult cystic fi brosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012;7:e45001.
5. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010;5:e11044.
6. Lynch SV, Bruce KD. The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med 2013;3:a009738.
7. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, Fligner CL, Singh PK. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012; 109:13769-13774.
8. Rudkjobing VB, Thomsen TR, Alhede M, Kragh KN, Nielsen PH, Johansen UR, Givskov M, Hoiby N, Bjarnsholt T. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis. J Clin Microbiol 2011;49: 4352-4355.
9. Rudkjobing VB, Thomsen TR, Alhede M, Kragh KN, Nielsen PH, Johansen UR, Givskov M, Hoiby N, Bjarnsholt T. The microorganisms in chronically infected end-stage and non-endstage cystic fibrosis patients. FEMS Immunol Med Microbiol 2012; 65:236-244.
10. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 2012;6:471-474.
11. Blainey PC, Milla CE, Cornfield DN, Quake SR. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fi brosis. Sci Transl Med 2012;4:153ra130.
12. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012;109:5809-5814.
13. Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL. Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 2003;41:4312-4317.
14. Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonellainfected pigs. Foodborne Pathog Dis 2008;5:459-472.
15. Dowd SE, Callaway TR, Wolcott RD, Sun Y, McKeehan T, Hagevoort RG, Edrington TS. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol 2008;8:125.
16. Kistler JO, Booth V, Bradshaw DJ, Wade WG. Bacterial community development in experimental gingivitis. PLoS One 2013;8: e71227.
17. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-7541.
18. Huys G, Vanhoutte T, Joossens M, Mahious AS, De Brandt E, Vermeire S, Swings J. Coamplification of eukaryotic DNA with 16S rRNA gene-based PCR primers: possible consequences for population fingerprinting of complex microbial communities. Curr Microbiol 2008;56:553-557.
19. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
20. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460-2461.
21. Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the human skin microbiome early in life. J Invest Dermatol 2011;131: 2026-2032.
22. Dowd SE, Delton Hanson J, Rees E, Wolcott RD, Zischau AM, Sun Y, White J, Smith DM, Kennedy J, Jones CE. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 2011; 20:40-47.
23. Eren AM, Zozaya M, Taylor CM, Dowd SE, Martin DH, Ferris MJ. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One 2011;6:e26732.
24. Swanson KS, Dowd SE, Suchodolski JS, Middelbos IS, Vester BM, Barry KA, Nelson KE, Torralba M, Henrissat B, Coutinho PM, et al. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J 2011;5:639-649.
25. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-5072.
26. Zhao J, Carmody LA, Kalikin LM, Li J, Petrosino JF, Schloss PD, Young VB, LiPuma JJ. Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One 2012;7:e33127.
27. Clarke K, Gorley R. PRIMER v6: User Manual/Tutorial. Lutton, Ivybridge, UK: PRIMER-E; 2006.
28. Clarke KR, Somerfield PJ, Gorley RN. Testing of null hypotheses in exploratory community analyses: similarity profiles and biota-environment linkage. J Exp Mar Biol Ecol 2008;366:56-69.
29. Rogers GB, Cuthbertson L, Hoffman LR, Wing PAC, Pope C, Hooftman DAP, Lilley AK, Oliver A, Carroll MP, Bruce KD, et al. Reducing bias in bacterial community analysis of lower respiratory infections. ISME J 2013;7:697-706.
30. Coenye T, Spilker T, Reik R, Vandamme P, Lipuma JJ. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J Clin Microbiol 2005;43: 3463-3466.
31. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008;177: 995-1001.
32. Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, Muhlebach MS, Boucher RC, Cardwell C, Doering G, et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 2011;66: 579-584.
33. Rayner MG, Zhang Y, Gorry MC, Chen Y, Post JC, Ehrlich GD. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998;279:296-299.
34. Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, et al.; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Infection, inflammation, and lung function decline in infants with cystic fi brosis. Am J Respir Crit Care Med 2011;184:75-81.
35. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009;180:146-152.
36. Zemanick ET, Wagner BD, Harris JK, Wagener JS, Accurso FJ, Sagel SD. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures. Pediatr Pulmonol 2010;45:569-577.
37. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ, Hanfland RA, Wohlford-Lenane C, Dohrn CL, Bartlett JA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010;2:29ra31.
38. Sun X, Olivier AK, Liang B, Yi Y, Sui H, Evans TI, Zhang Y, Zhou W, Tyler SR, Fisher JT, et al . Lung phenotype of juvenile and adult CFTR-knockout ferrets. Am J Respir Cell Mol Biol 2014;50:502-512.